Latest News & Features
Americas
Controversial rule precludes a patent review if there is parallel litigation | Big pharma and tech companies insist the rule is “arbitrary and capricious” |
US agency backs Vidal’s authority, calling a proposed intervention “unnecessary”. 14 November 2023
Biotechnology
Federal Circuit rejects appeal in patent dispute with California’s Cloudbreak Theraputics | Court stated failure to prove concrete injury. 9 November 2023
Big Pharma
Commission targets big pharma companies over ‘improper listings’ | Agency argues that alleged inaccuracies may delay lower-cost generic drug competition, stall drug development, and stifle innovation. 9 November 2023
Big Pharma
Genomics company’s in-house attorney removed from case over links with patent infringement case | Court denied plaintiff’s motion to disqualify entire legal team. 7 November 2023
Americas
Appeals court faults lower court’s claim construction and its reliance on intrinsic evidence alone | Court emphasises that extrinsic evidence is needed in litigation over heart disease drug. 7 November 2023
Generics
District court denies Norwich’s motion to compel FDA to grant approval for its version of popular IBS medication | Court also grants summary judgment in favour of FDA and Norwich’s competitor. 2 November 2023
Medtech
Precedential ruling finds errors in lower court’s findings in a case concerning medical devices | Earlier verdict has been vacated and remanded. 2 November 2023
Big Pharma
US Court of Appeals dismisses appeal due to a ‘lack of jurisdiction’ | Dispute against Jiangsu Hengrui Pharmaceuticals began as a patent suit but the discovery process prompted trade secret claims. 31 October 2023
Biotechnology
RSB Spine files patent infringement lawsuit against competitors over spinal implant products | Plaintiff claims the defendants had knowledge of patent infringement. 31 October 2023
Americas
Biopharmaceutical patent partner leads team of technical advisors and an associate in California | Partner experienced in patent prosecution, freedom-to-operate analysis, and assessing infringement validity in the pharma and biotech industry. 26 October 2023